Is the risk of atherosclerotic cardiovascular disease different between genotype determined or measured LP(a) levels?
Immune-inflammatory proteomics associated with elevated cardiovascular risk in genetically determined familial hypercholesterolemia
Modelling a two-stage screen for autosomal dominant familial hypercholesterolaemia (FH) in UK biobank
Universal screening is an effective strategy for detecting patients with familial hypercholesterolemia